Director, Cell Therapy Vein-to-Vein Operations

Start free →

Or apply yourself on the official page →

About the role

Introduction to role: At AstraZeneca Cell Therapy, we are building the capabilities required to deliver complex, personalized therapies through a highly coordinated, patient-centered, and digitally enabled operating model. As we evolve from traditional clinical logistics coordination to Vein-to-Vein Operations, we are shifting our focus toward patient and order orchestration, proactive journey management, real-time visibility, exception management, and customer experience that will scale towards Commercial phase and AstraZeneca’s cell therapy ambition.  The Director leads the Vein-to-Vein Operations organizational capability, governance framework, readiness approach, and performance model that enable the transition from reactive shipment support to proactive end-to-end orchestration and support Vein-to-Vein readiness for global expansion and commercial scale. This role partners closely with Clinical Operations, Manufacturing, Quality, Trade Compliance, Digital, Delivery Performance, Packaging, external logistics providers, and other stakeholders to ensure the V2V model is effective, compliant, scalable, and centered on the patient journey. This is a hybrid position with a requirement to work in the office three days a week. Accountabilities: • Lead the Vein-to-Vein Operations function, with accountability for organizational design, role clarity, decision rights, governance, ways of working, and execution performance across the end-to-end patient and product journey.  • Own the Vein-to-Vein Operations operating model centered on patient and order orchestration, proactive patient journey management, customer experience, and digitally enabled control tower visibility.  • Establish and lead the V2V orchestration model, including the 24/7 global control tower mindset and the operating rhythms required to monitor product and patient journeys in real time and intervene proactively.  • Lead product journey monitoring capability, ensuring all critical milestones across collection, manufacturing, transit, release, and return delivery are visible, monitored, and linked to timely operational response.  • Own slot execution and coordination capability, ensuring the organization can effectively manage the forecast-to-booked slot pipeline and operate within defined planning rules and capacity parameters.  • Ensure robust V2V and COI/COC traceability, including appropriate business process ownership, standard templates, process controls, and operational discipline required to maintain traceability and GMP/GDP compliance.  • Own exception management and escalation capability, ensuring clear playbooks, decision pathways, and cross-functional escalation processes are in place when patient or product journeys move off the expected path.  • Lead courier and logistics provider engagement for active Vein-to-Vein journeys, ensuring real-time milestone visibility, escalation of off-path events, and coordinated recovery actions for shipment delays, temperature excursions, missed milestones, and other transport-related disruptions impacting patient timelines.  • Lead customer experience delivery for treatment centers and internal stakeholders by establishing service expectations, communication standards, escalation pathways, and a coordinated end-to-end experience in collaboration with Patient Operations.  • Own operational performance management across Vein-to-Vein Operations, including service reliability, milestone adherence, exception trends, customer experience, and execution quality.  • Build and Lead cross-functional governance and decision-making for operational, compliance, capacity, and service issues impacting V2V execution.  • Ensure operational readiness and scale-up for new studies, countries, sites, third parties, products, lan

View the official posting →